An NBC News story on OpenEvidence marks a real inflection point in clinical AI. According to company representatives cited by NBC, nearly two-thirds of US physicians, roughly 650,000 doctors, now actively use the tool. In April alone, they reported nearly 27 million...
Last Friday at dinner, a friend asked about hantavirus. She had seen alarming headlines about cases connected to a cruise ship and asked, “Should we be worried?” She had already searched the web. A few news articles. Some government websites. Medical papers published...
A recent Mayo Clinic study (REDMOD, published in Gut) makes that point with unusual clarity. The investigators retrospectively analyzed nearly 2,000 abdominal CT scans, including scans from patients who were later diagnosed with pancreatic cancer and matched...
Today, we’re introducing Truveta Intelligence, a new AI-powered experience that delivers real-time insights from continuously refreshed real-world data in minutes, not months. For life sciences, public health, and healthcare organizations, this means something simple...
The New York Times covered Microsoft’s Copilot Health launch last week. It’s worth reading because it reveals where the entire consumer health AI category stands right now. First, let me say what I genuinely believe: Consumer health AI is one of the most important...
Clinical trials rarely stall because of science alone. More often, they slow due to recruitment challenges—particularly in rare and clinically complex conditions. When that happens, knowing that eligible patients exist is not enough. Sponsors need to locate eligible...
